Sumul Raval Tells Patients With GBM, "I'm Your Quarterback"

The novel glioblastoma treatment, APTN-101, had its new drug application accepted by the FDA.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Matt Newman, who was diagnosed with brain cancer at 39, but refuses to let cancer define the legacy he has made.

In August 2024, the FDA approved six new cancer treatments, including some that haven’t previously been approved.

In this week’s episode, we spoke with the founder and CEO of Savor Health on the importance of nutrition for patients and caregivers before, during and after cancer treatment.

For patients with glioblastoma, collecting information about their disease and treatment options is important before providing informed consent.

The FDA has approved Voranigo to treat certain patients with grade 2 astrocytoma or oligodendroglioma with select mutations, following surgery.